不同疗程四联疗法根除幽门螺杆菌的疗效观察

目的 研究泮托拉唑短程四联4、5、7d疗法根除幽门螺杆菌(Hp)的疗效.方法166例经胃镜证实Hp阳性的重度胃炎患者随机分为泮托拉唑四联疗法4 d组、5 d组和7 d组,均给予泮托拉唑40mg+枸橼酸铋钾220 nag+克拉霉素250 mg+阿莫西林1 g,每日2次治疗,泮托拉唑疗程1周,枸橼酸铋钾疗程2周,克拉霉素、阿莫西林疗程在3组分别为4、5和7 d.疗程结束4周后复查Hp,观察Hp根除率、症状缓解率及不良反应等.结果泮托拉唑四联疗法4、5和7d组Hp根除率分别为73.8%(45/61)、75.9%(41/54)和80.4%(41/51);疼痛缓解率分别为82.4%(42/51)、85.1%(40/47)和88.9%(40/45),各组之间比较差异均无统计学意义(均P>0.05).结论泮托拉唑四联短程疗法(4或5 d)为安全、有效、符合药物经济学要求的根除Hp的方案.

Study of 4-,5- and 7-day pantoprazole quadruple therapy regimens in the treatment of Helicobacter pylori Infection

Objective To compare the efficacy of pantoprazoh based short-term quadruple regimens in the treatment of Helicobacter pylori (H. Pylori) infection for 4 days,5 days or 7days. Methods 166 patients with H. Pylori associated severe gastritis were randomly divided into pantoprozole quadruple regimens of 4-day group (n =61) ,5-day group (n = 54) or 7-day group (n = 51). The regimen was pantoprazole 40 mg,bismuth potassium citrate 220 mg,elarithromycin 250 mg and amoxicillin 1 g twice daily. The patients received pantoprazole for 1 week, bismuth potassium citrate for 2 weeks,clarithromycin and amoxicillin for 4 days,5 days or 7 days respectively. The H. Pylori eradication and symptomatic relief was determinded by 13C-UBT at least 4 weeks after the therapy. Results The H. Pylori eradication rates of 4-day,5-day or 7-day panteprazole quadruple regimens were 73.8% (45/61) ,75.9% (41/54) and 80.4% (41/51) respectively. The pain relief rates were 82.4% (42/51) ,85.1% (40/47) and 88.9% (40/45) in 4-day,5-day and 7 day group. Conclusion The 4-day and 5- day pantoprazoh based quadrual therapy is a short- term, effective, safe and lower therapeutic- cost regimen for H. Pylori eradication.